Frequently Asked Questions
Uterine fibroids are non-cancerous (benign) growths in or around the uterus and will be found in approximately 70%-80% of women in the United States. Learn more About Fibroids.
Many women with fibroids have no symptoms and require no intervention. However, fibroids can cause symptoms that significantly interfere with daily activities. Women diagnosed with uterine fibroids also have a higher risk of infertility compared to women without fibroids. Learn more at Fibroid Treatments.
The Sonata System is an innovative medical device that received FDA clearance in 2018 for use in the United States and CE mark for use and sale in Europe since 2014.
The Sonata Treatment is an incision-free treatment option for women with symptomatic uterine fibroids. Learn more at Sonata Treatment.
The Sonata handpiece is inserted by the doctor through your vagina and into the uterus. Radiofrequency energy is delivered to the fibroid, causing it to shrink over time and relieve symptoms. The procedure is typically short, between 15 and 60 minutes, depending on the number and size of fibroids treated. Learn more at How Sonata Works.
Positive outcomes of procedures using the Sonata Treatment have been published in peer-review medical journals and clinical studies demonstrate that Sonata is a safe and effective uterine fibroid treatment. Learn more about Clinical Trial Results.
The Sonata Treatment is an outpatient procedure in the United States. Patients are scheduled to return home the same day.
Most side effects are typically minor and temporary, such as spotting and cramping. The doctor should discuss all potential risks in detail. For complete safety information, see Safety Information.
The safety and effectiveness of the Sonata Treatment in women who desire future pregnancy has not been established. Potential risks or benefits regarding pregnancy are unknown.
The Sonata System was developed and is manufactured by Gynesonics, a women’s health company, headquartered in California. Visit the website.